Allergy Drops vs Sublingual Tablets: How They Differ

No. Both are forms of sublingual immunotherapy taken under the tongue, but they are regulated very differently. The four tablets, Grastek, Oralair, Ragwitek and Odactra, are FDA-approved prescription drugs, each targeting a single allergen such as grass pollen, ragweed or house dust mite. Liquid allergy drops are custom-compounded from allergen extracts and used off-label, meaning they are not FDA-approved. Drops can be tailored to combine several allergens in one daily dose, while each tablet covers only one. Because of these differences, coverage, breadth of treatment and the prescribing process are not the same between the two formats.

The FDA approved specific single-allergen tablets after manufacturers completed large clinical trials demonstrating safety and efficacy for one defined allergen, allowing them to be sold as standardized drugs. Custom liquid drops are compounded individually for each patient from FDA-approved extracts, but the sublingual route for multi-allergen compounded drops has not gone through that approval pathway, so it remains off-label. Compounded medications generally are not FDA-approved as products. This regulatory gap is why drops are usually paid out of pocket while tablets may be partly covered, even though both rely on the same desensitization principle.

Yes, that is one of the main practical advantages of custom liquid drops. Because the formula is compounded specifically for you, a provider can combine extracts for several of your confirmed allergens, such as grass, dust mite and pet dander, into a single daily dose. FDA-approved tablets do not allow this; each tablet treats only one allergen, so someone with multiple sensitivities would need multiple separate tablet products, which is generally impractical. Allergy testing first identifies your specific triggers so the formula can be matched to them. Your provider decides which allergens are appropriate to include based on your results and history.

Often, yes, at least in part. Because the four sublingual tablets are FDA-approved prescription drugs, many insurance plans cover them like other medications, though copays and prior authorization rules vary by plan and allergen. Custom liquid drops are compounded and used off-label, so private insurance, Medicare and Medicaid generally do not cover the drops themselves. Drops are, however, HSA/FSA-eligible, letting you use pre-tax dollars. Coverage details change frequently, so confirm specifics with your insurer and pharmacy before starting either treatment, and ask whether any clinical visit components are billable separately.

There is no clear winner for everyone. The FDA-approved tablets have strong trial evidence for their single allergen, while custom drops have moderate-grade evidence across a broader range of allergens. Direct head-to-head studies are limited, so neither form can be called reliably superior. The better choice usually depends on your situation: tablets may suit someone with a single dominant allergen who values FDA approval and possible coverage, while drops may fit people with multiple sensitivities who want one combined daily formula. Neither cures allergies, and both typically require several years of consistent use to build lasting benefit.